Stock NNAG 99 ACQUPAR
Add to a list
To use this feature you must be a member
Log inSign up

Financials 99 ACQUPAR

Equities

NNAG

US65445K1016

Delayed Nasdaq
Other stock markets
 11:38:18 2024-06-03 am EDT 		5-day change 1st Jan Change
10.47 USD -0.10% Intraday chart for 99 ACQUPAR 0.00% +2.75%
Apr. 05 99 Acquisition Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 13 Nava Health MD, LLC entered into a definitive merger agreement to acquire 99 Acquisition Group Inc. in a reverse merger transaction for $320 million. CI

Valuation

Fiscal Period: December 2023
Capitalization 1 102.7
Enterprise Value (EV) 1 102.4
P/E ratio 70.6 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF 2,631,122,791 x
FCF Yield 0%
Price to Book -41.1 x
Nbr of stocks (in thousands) 10,075
Reference price 2 10.19
Announcement Date 4/5/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales - -
EBITDA - -
EBIT - -0.115
Operating Margin - -
Earnings before Tax (EBT) 1 -0.003451 1.051
Net income 1 -0.003451 0.7561
Net margin - -
EPS - 0.1443
Free Cash Flow - 0.0389
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - 5.15%
Dividend per Share - -
Announcement Date 2/22/23 4/5/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 0.02 -
Net Cash position 1 - 0.22
Leverage (Debt/EBITDA) - -
Free Cash Flow - 0.04
ROE (net income / shareholders' equity) - -61.1%
ROA (Net income/ Total Assets) - -0.18%
Assets 1 - -409.8
Book Value Per Share 2 0.0100 -0.2500
Cash Flow per Share 2 0 0.0300
Capex - -
Capex / Sales - -
Announcement Date 2/22/23 4/5/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NNAG Stock
  4. Financials 99 ACQUPAR